Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP) Laura Francisco; Marta Cruz-Cañete; Carlos Pérez; José Antonio Couceiro; Enrique Otheo; Cristian Launes; Carlos Rodrigo; Ana Belén Jiménez; Marta Llorente; Abián Montesdeoca; José Rumbao; Cristina Calvo; Susana Frago; Alfredo Tagarro;

Respiratory syncytial virus infections requiring hospitalization in patients with primary immunodeficiency Luis Ignacio González-Granado; Andrea Martín-Nalda; Laia Alsina; Olaf Neth; Manuel Santamaría; Pere Soler-Palacín;

Serogroup C invasive meningococcal disease in the post-vaccine era and vaccine failures Neus Rius; Mayli Lung; Carolina Fernández-San José; Tamara Iglesias; Juliana Esperalba; Fernado A. Moraga-Llop; Pere Soler-Palacín;